Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Obesity and CYP3A4[original query] |
|---|
| Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated Biomarkers. Molecular pharmaceutics 2016 Jan . Lloret-Linares Celia, Miyauchi Eisuke, Luo Huilong, Labat Laurence, Bouillot Jean-Luc, Poitou Christine, Oppert Jean-Michel, Laplanche Jean-Louis, Mouly Stephane, Scherrmann Jean-Michel, Uchida Yasuo, Tachikawa Masanori, Terasaki Tetsuya, Bergmann Jean-François, Decleves Xavi |
| Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite. European journal of clinical pharmacology 2017 Sep . Danielak Dorota, Kara?niewicz-?ada Marta, Komosa Anna, Burchardt Pawe?, Lesiak Maciej, Kruszyna ?ukasz, Graczyk-Szuster Agnieszka, G?ówka Francisz |
| Investigating the Effect of Demographics, Clinical Characteristics, and Polymorphism of MDR-1, CYP1A2, CYP3A4, and CYP3A5 on Clopidogrel Resistance. Journal of cardiovascular pharmacology 2018 11 72 (6): 296-302. Al-Husein Belal A, Al-Azzam Sayer I, Alzoubi Karem H, Khabour Omar F, Nusair Mohammad B, Alzayadeen Sam |
| Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial. Scientific reports 2019 Nov 9 (1): 17833. Gómez-Silva Magdalena, Piñeyro-Garza Everardo, Vargas-Zapata Rigoberto, Gamino-Peña María Elena, León-García Armando, de León Mario Bermúdez, Llerena Adrián, León-Cachón Rafael B |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: